Soliris® (eculizumab)
| Full Name | Soliris® (eculizumab) |
| Drug | Soliris |
| Manufacturer | Alexion Pharmaceuticals, a subsidiary of AstraZeneca |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis |
| Disease | Paroxysmal Nocturnal Hemoglobinuria (PNH); Atypical Hemolytic Uremic Syndrome (aHUS) |
| Therapeutic Area | Hematology |
| Enrollment Form Link | Soliris Enrollment Form |
| Phone Number | N/A |
| Fax Number | N/A |
| Product Website | solirisnmosd.com |